Gaudium IVF IPO Fully Subscribed on Day 2; Retail & NII Lead Demand

The initial public offering (IPO) of Gaudium IVF and Women Health was fully subscribed on Day 2 of bidding, driven primarily by strong participation from retail and non-institutional investors.

Category-wise Subscription Update

The IPO has witnessed strong demand across investor categories:

Retail Investors: 4.07x

Non-Institutional Investors (NII): 4.65x

Overall Subscription: 3.04x

The strong participation from both retail and NII segments indicates improving investor confidence in the issue.

Gaudium IVF IPO GMP Today

According to grey market sources:

GMP is quoted at around ₹7.5, indicating a potential listing gain of 9–11% over the upper price band of ₹79.

At current levels, the estimated listing price could be around ₹86–₹87 per share, subject to market conditions.


Disclaimer: GMP is an unofficial indicator derived from market sources and should not be considered a reliable or assured measure of listing gains.

Gaudium IVF IPO Fully Subscribed on Day 2; Retail & NII Lead Demand

The initial public offering (IPO) of Gaudium IVF and Women Health was fully subscribed on Day 2 of bidding, driven primarily by strong participation from retail and non-institutional investors.

Category-wise Subscription Update

The IPO has witnessed strong demand across investor categories:

Retail Investors: 4.07x

Non-Institutional Investors (NII): 4.65x

Overall Subscription: 3.04x

The strong participation from both retail and NII segments indicates improving investor confidence in the issue.

Gaudium IVF IPO GMP Today

According to grey market sources:

GMP is quoted at around ₹7.5, indicating a potential listing gain of 9–11% over the upper price band of ₹79.

At current levels, the estimated listing price could be around ₹86–₹87 per share, subject to market conditions.


Disclaimer: GMP is an unofficial indicator derived from market sources and should not be considered a reliable or assured measure of listing gains.